Annual Shareholders Equity
$126.55 M
+$442.40 K+0.35%
December 31, 2023
Summary
- As of March 6, 2025, OPRX annual stockholders equity is $126.55 million, with the most recent change of +$442.40 thousand (+0.35%) on December 31, 2023.
- During the last 3 years, OPRX annual shareholders equity has risen by +$76.58 million (+153.24%).
- OPRX annual shareholders equity is now -3.67% below its all-time high of $131.38 million, reached on December 31, 2021.
Performance
OPRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$114.47 M
-$6.55 M-5.41%
September 30, 2024
Summary
- As of March 6, 2025, OPRX quarterly stockholders equity is $114.47 million, with the most recent change of -$6.55 million (-5.41%) on September 30, 2024.
- Over the past year, OPRX quarterly shareholders equity has dropped by -$1.64 million (-1.41%).
- OPRX quarterly shareholders equity is now -18.71% below its all-time high of $140.82 million, reached on June 30, 2022.
Performance
OPRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
OPRX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.3% | -1.4% |
| 3 y3 years | +153.2% | -12.9% |
| 5 y5 years | +585.6% | +155.2% |
OPRX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.7% | +0.3% | -18.7% | at low |
| 5 y | 5-year | -3.7% | +182.1% | -18.7% | +163.1% |
| alltime | all time | -3.7% | >+9999.0% | -18.7% | >+9999.0% |
OptimizeRx Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $114.47 M(-5.4%) |
| Jun 2024 | - | $121.02 M(-1.2%) |
| Mar 2024 | - | $122.54 M(-3.2%) |
| Dec 2023 | $126.55 M(+0.4%) | $126.55 M(+9.0%) |
| Sep 2023 | - | $116.11 M(+0.3%) |
| Jun 2023 | - | $115.82 M(-6.6%) |
| Mar 2023 | - | $123.96 M(-1.7%) |
| Dec 2022 | $126.11 M(-4.0%) | $126.11 M(-2.7%) |
| Sep 2022 | - | $129.57 M(-8.0%) |
| Jun 2022 | - | $140.82 M(+7.5%) |
| Mar 2022 | - | $131.05 M(-0.3%) |
| Dec 2021 | $131.38 M(+162.9%) | $131.38 M(+3.6%) |
| Sep 2021 | - | $126.82 M(+1.7%) |
| Jun 2021 | - | $124.68 M(+2.3%) |
| Mar 2021 | - | $121.84 M(+143.8%) |
| Dec 2020 | $49.97 M(+11.4%) | $49.97 M(+7.1%) |
| Sep 2020 | - | $46.68 M(+7.3%) |
| Jun 2020 | - | $43.50 M(-0.3%) |
| Mar 2020 | - | $43.63 M(-2.8%) |
| Dec 2019 | $44.86 M(+143.0%) | $44.86 M(+9.1%) |
| Sep 2019 | - | $41.14 M(-1.8%) |
| Jun 2019 | - | $41.91 M(+115.6%) |
| Mar 2019 | - | $19.44 M(+5.3%) |
| Dec 2018 | $18.46 M(+196.7%) | $18.46 M(+7.3%) |
| Sep 2018 | - | $17.20 M(+8.9%) |
| Jun 2018 | - | $15.80 M(+131.2%) |
| Mar 2018 | - | $6.83 M(+9.9%) |
| Dec 2017 | $6.22 M(-20.4%) | $6.22 M(+2.8%) |
| Sep 2017 | - | $6.05 M(-6.5%) |
| Jun 2017 | - | $6.47 M(-8.3%) |
| Mar 2017 | - | $7.06 M(-9.6%) |
| Dec 2016 | $7.81 M | $7.81 M(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $8.04 M(-1.4%) |
| Jun 2016 | - | $8.16 M(-4.6%) |
| Mar 2016 | - | $8.55 M(-4.4%) |
| Dec 2015 | $8.94 M(+94.0%) | $8.94 M(-3.2%) |
| Sep 2015 | - | $9.24 M(+96.5%) |
| Jun 2015 | - | $4.70 M(+2.7%) |
| Mar 2015 | - | $4.58 M(-0.7%) |
| Dec 2014 | $4.61 M(+176.4%) | $4.61 M(-5.0%) |
| Sep 2014 | - | $4.85 M(+1.5%) |
| Jun 2014 | - | $4.78 M(+3.9%) |
| Mar 2014 | - | $4.60 M(+175.9%) |
| Dec 2013 | $1.67 M(+18.7%) | $1.67 M(-19.3%) |
| Sep 2013 | - | $2.07 M(+15.8%) |
| Jun 2013 | - | $1.78 M(+28.3%) |
| Mar 2013 | - | $1.39 M(-1.0%) |
| Dec 2012 | $1.40 M(-11.6%) | $1.40 M(+5.3%) |
| Sep 2012 | - | $1.33 M(-4.1%) |
| Jun 2012 | - | $1.39 M(-1.3%) |
| Mar 2012 | - | $1.41 M(-11.4%) |
| Dec 2011 | $1.59 M(-16.1%) | $1.59 M(-16.8%) |
| Sep 2011 | - | $1.91 M(+47.0%) |
| Jun 2011 | - | $1.30 M(-22.6%) |
| Mar 2011 | - | $1.68 M(-11.3%) |
| Dec 2010 | $1.89 M(+122.2%) | $1.89 M(+32.9%) |
| Sep 2010 | - | $1.43 M(-22.2%) |
| Jun 2010 | - | $1.83 M(+195.7%) |
| Mar 2010 | - | $619.30 K(-27.3%) |
| Dec 2009 | $852.30 K(-64.9%) | $852.30 K(-24.0%) |
| Sep 2009 | - | $1.12 M(-20.9%) |
| Jun 2009 | - | $1.42 M(-19.4%) |
| Mar 2009 | - | $1.76 M(-27.4%) |
| Dec 2008 | $2.43 M(-2655.8%) | $2.43 M |
| Dec 2007 | -$94.90 K | - |
FAQ
- What is OptimizeRx annual stockholders equity?
- What is the all time high annual shareholders equity for OptimizeRx?
- What is OptimizeRx annual shareholders equity year-on-year change?
- What is OptimizeRx quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for OptimizeRx?
- What is OptimizeRx quarterly shareholders equity year-on-year change?
What is OptimizeRx annual stockholders equity?
The current annual shareholders equity of OPRX is $126.55 M
What is the all time high annual shareholders equity for OptimizeRx?
OptimizeRx all-time high annual stockholders equity is $131.38 M
What is OptimizeRx annual shareholders equity year-on-year change?
Over the past year, OPRX annual stockholders equity has changed by +$442.40 K (+0.35%)
What is OptimizeRx quarterly stockholders equity?
The current quarterly shareholders equity of OPRX is $114.47 M
What is the all time high quarterly shareholders equity for OptimizeRx?
OptimizeRx all-time high quarterly stockholders equity is $140.82 M
What is OptimizeRx quarterly shareholders equity year-on-year change?
Over the past year, OPRX quarterly stockholders equity has changed by -$1.64 M (-1.41%)